“arch-venture-partners” Archives

in
Entry Author Date Location
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More 05/17/19 San Diego
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic 04/30/19 San Diego
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases 02/28/19 San Francisco
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell 02/07/19 New York
LunaDNA Health Data Platform to Merge with Genetic Alliance Database 01/22/19 San Diego
Gossamer Bio Files for IPO at End of Year in Which It Raised $330M 12/24/18 San Diego
Ligand Inks Deal, Ionis Details Succession Plan, & More SD Biotech 12/21/18 San Diego
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca 12/18/18 San Diego
LunaDNA Offers Stock for Data in Bid to Build Research Database 12/07/18 San Diego
Nebula Genomics Touts Free DNA Sequencing to Coax Health Data Sharing 11/15/18 Boston
Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology 10/31/18 San Francisco
With CRISPR’s Help, KSQ Touts 13 Cancer Drugs and Bags Another $80M 09/28/18 Boston
OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies 09/11/18 Texas
New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs 08/13/18 New York
What’s Hot in Seattle Biotech: Tech, Life Sciences Convergence & More 06/19/18 Seattle
Mindstrong Adds $15M for Tech That Predicts Mental Health Changes 06/14/18 San Francisco
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkin 05/23/18 New York
Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout 05/18/18 National
Seattle Venture Capital Watch: Nohla, Auth0, Glowforge & More 05/15/18 Seattle
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial 03/19/18 San Francisco
In Biggest Biotech IPO of 2017, Denali Raises $248M for Neuro Drugs 12/08/17 San Francisco
Metacrine Raises $22M to Advance New Drugs for Chronic Liver Disease 12/07/17 San Diego
ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest 11/14/17 Boston
OncoResponse Buys Paganini Biopharma to Add Cancer Drug to Pipeline 11/08/17 Texas
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Page 1 of 17 next page »